These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25592573)

  • 21. MOST: detecting cancer differential gene expression.
    Lian H
    Biostatistics; 2008 Jul; 9(3):411-8. PubMed ID: 18048648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer outlier differential gene expression detection.
    Wu B
    Biostatistics; 2007 Jul; 8(3):566-75. PubMed ID: 17021278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parsimonious selection of useful genes in microarray gene expression data.
    González-Navarro FF; Belanche-Muñoz LA
    Adv Exp Med Biol; 2011; 696():45-55. PubMed ID: 21431545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Handling multiple testing while interpreting microarrays with the Gene Ontology Database.
    Osier MV; Zhao H; Cheung KH
    BMC Bioinformatics; 2004 Sep; 5():124. PubMed ID: 15350198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
    Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying mutated driver pathways in cancer by integrating multi-omics data.
    Wu J; Cai Q; Wang J; Liao Y
    Comput Biol Chem; 2019 Jun; 80():159-167. PubMed ID: 30959272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lex-SVM: exploring the potential of exon expression profiling for disease classification.
    Yuan X; Zhao Y; Liu C; Bu D
    J Bioinform Comput Biol; 2011 Apr; 9(2):299-316. PubMed ID: 21523934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feature selection in gene expression data using principal component analysis and rough set theory.
    Mishra D; Dash R; Rath AK; Acharya M
    Adv Exp Med Biol; 2011; 696():91-100. PubMed ID: 21431550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer.
    Aris VM; Cody MJ; Cheng J; Dermody JJ; Soteropoulos P; Recce M; Tolias PP
    BMC Bioinformatics; 2004 Nov; 5():185. PubMed ID: 15569388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using uncorrelated discriminant analysis for tissue classification with gene expression data.
    Ye J; Li T; Xiong T; Janardan R
    IEEE/ACM Trans Comput Biol Bioinform; 2004; 1(4):181-90. PubMed ID: 17051700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A SATS algorithm for jointly identifying multiple differentially expressed gene sets.
    Yang TY
    Stat Med; 2011 Jul; 30(16):2028-39. PubMed ID: 21472762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid L
    Huang HH; Liang Y
    Comput Methods Programs Biomed; 2018 Oct; 164():65-73. PubMed ID: 30195432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A framework for list representation, enabling list stabilization through incorporation of gene exchangeabilities.
    Soneson C; Fontes M
    Biostatistics; 2012 Jan; 13(1):129-41. PubMed ID: 21908866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PATIENT-SPECIFIC DATA FUSION FOR CANCER STRATIFICATION AND PERSONALISED TREATMENT.
    Gligorijević V; Malod-Dognin N; Pržulj N
    Pac Symp Biocomput; 2016; 21():321-32. PubMed ID: 26776197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interval based fuzzy systems for identification of important genes from microarray gene expression data: Application to carcinogenic development.
    De RK; Ghosh A
    J Biomed Inform; 2009 Dec; 42(6):1022-8. PubMed ID: 19591962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Which statistical significance test best detects oncomiRNAs in cancer tissues? An exploratory analysis.
    Tang W; Liao Z; Zou Q
    Oncotarget; 2016 Dec; 7(51):85613-85623. PubMed ID: 27784000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to decide which are the most pertinent overly-represented features during gene set enrichment analysis.
    Barriot R; Sherman DJ; Dutour I
    BMC Bioinformatics; 2007 Sep; 8():332. PubMed ID: 17848190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene selection from microarray data for cancer classification--a machine learning approach.
    Wang Y; Tetko IV; Hall MA; Frank E; Facius A; Mayer KF; Mewes HW
    Comput Biol Chem; 2005 Feb; 29(1):37-46. PubMed ID: 15680584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.